Immunology Tests

ACE (Angiotensin Converting Enzyme) CSF Test in Dubai and across the UAE to aid in the diagnosis of neurosarcoidosis and other central nervous system (CNS) disorders. This specialized test measures ACE levels in **cerebrospinal fluid (CSF)**, providing critical insight when sarcoidosis affects the brain or spinal cord. Results available within 7–10 days.

Overview

The ACE (Angiotensin Converting Enzyme) in CSF test measures the concentration of ACE — an enzyme produced by activated macrophages — in cerebrospinal fluid. While sarcoidosis most commonly affects the lungs and lymph nodes, it can involve the nervous system (neurosarcoidosis), leading to serious neurological symptoms. Since neurosarcoidosis is difficult to diagnose with imaging alone, elevated CSF ACE levels serve as a supportive biomarker. This test is performed in specialized labs and results are typically available within 7–10 business days.

Why You Need This Test

• Support the diagnosis of neurosarcoidosis — a rare but serious form of sarcoidosis affecting the brain or spinal cord.
• Evaluate unexplained cranial nerve palsies (e.g., facial paralysis).
• Investigate chronic meningitis, seizures, or hypothalamic dysfunction.
• Assess patients with known systemic sarcoidosis and new neurological symptoms.
• Rule out other causes of CNS inflammation (e.g., infections, multiple sclerosis).
• Monitor disease activity in confirmed neurosarcoidosis cases.
• Available at accredited labs in Dubai, Abu Dhabi, and across the UAE with expert neurology support.

Symptoms & Risk Factors

Common Neurological Symptoms

• Facial nerve palsy (Bell’s palsy-like symptoms)
• Chronic headaches or dizziness
• Vision changes or double vision
• Seizures or altered mental status
• Weakness, numbness, or balance problems
• Hormonal imbalances (due to hypothalamic/pituitary involvement)

Risk Factors

• Known systemic sarcoidosis (lung, skin, or eye involvement)
• Age 20–50 years — peak incidence for sarcoidosis
• African or Scandinavian descent — higher risk groups
• Autoimmune conditions or immune dysregulation
• Family history of sarcoidosis
• Prolonged unexplained neurological symptoms without clear cause

How the Test Works

Activated macrophages in sarcoid granulomas produce high levels of ACE, which can leak into the CSF when the central nervous system is involved. The CSF ACE test measures this enzyme directly in cerebrospinal fluid, offering a biochemical clue to neuroinflammation.

• Step 1 — Clinical referral: ordered by a neurologist or specialist based on symptoms and imaging.
• Step 2 — Lumbar puncture (spinal tap): a trained physician collects CSF from the lower back.
• Step 3 — Sample processing: CSF is sent to a specialized lab for ACE analysis.
• Step 4 — Results: securely delivered within 7–10 business days.

This test is not a standalone diagnosis but provides valuable support when combined with MRI, clinical findings, and exclusion of infections.

Sample Type

• We take: Cerebrospinal fluid (CSF) via lumbar puncture
• Volume required: 2–5 mL (collected in sterile tubes without preservatives)
• Collection method: lumbar puncture (spinal tap) at hospital or clinic
• Handling: sample must be kept at room temperature and processed promptly
• Turnaround: requires specialized testing — not available in all labs
• Note: serum ACE may also be tested, but CSF ACE is more specific for neuro involvement

Risks & Safety

• Minor risks associated with lumbar puncture — most common is post-procedure headache.
• Low risk of infection, bleeding, or nerve irritation — rare when performed by experienced clinicians.
• No sedation required — usually performed with local anesthesia.
• Safe for adults; rarely performed in children unless strongly indicated.
• Recovery: rest for a few hours post-procedure; most resume normal activity the next day.

Result Interpretation

Normal Range

• Normal CSF ACE: < 2.0 U/L (lab-dependent — ranges vary)
• Very low or undetectable in healthy individuals

Elevated Levels

• May indicate:
  • Neurosarcoidosis (most clinically relevant cause)
  • CNS infections like tuberculosis or fungal meningitis (rare)
  • Multiple sclerosis or other inflammatory conditions (less common)
  • Lymphoma or leukemia with CNS involvement

Normal or Low Levels

• Do not rule out neurosarcoidosis — some patients have normal CSF ACE despite active disease.
• Supports alternative diagnoses if clinical picture allows.

Consequences if Untreated

• Progressive neurological damage — including vision loss, paralysis, or seizures.
• Pituitary or hypothalamic dysfunction leading to hormonal imbalances.
• Chronic pain, fatigue, or cognitive decline.
• Increased risk of stroke or hydrocephalus in advanced cases.
• Reduced quality of life due to unmanaged symptoms.

Factors Affecting Test Results

• Systemic sarcoidosis activity: high serum ACE may correlate with CSF levels.
• Medications: corticosteroids or immunosuppressants may lower ACE levels.
• Lab methodology: different assays may yield varying results — use consistent labs for monitoring.
• Contamination: blood in CSF can interfere with accuracy.
• Other CNS diseases: TB, fungal infections, or lymphoma may elevate ACE.
• Age and lab reference range: must be interpreted in context.

FAQs

Limitations

• Not a standalone diagnostic tool — must be combined with clinical evaluation, MRI, and other tests.
• Sensitivity is moderate — up to 50–70% of neurosarcoidosis cases show elevated CSF ACE.
• Available only in specialized laboratories — not routinely offered.
• Requires invasive procedure (lumbar puncture) for sample collection.
• May be affected by medications or concurrent infections.

Book Your ACE (Angiotensin Converting Enzyme) CSF Test Today

Seek answers for unexplained neurological symptoms — especially if you have systemic sarcoidosis or chronic meningitis.

• Performed at Accredited Hospitals & Neurology Centers (Dubai, Abu Dhabi, Sharjah & All Emirates)
• Detailed, Specialist-Validated Results in 7–10 Days
• Price: AED 750
• ✅ Advanced Labs | Neuroimmunology & Sarcoidosis Expertise
• 🩺 Lumbar Puncture by Experienced Clinicians
• 🔒 Confidential & Secure Reporting

ACE (Angiotensin Converting Enzyme) Serum Test in Dubai and across the UAE to aid in the diagnosis and monitoring of sarcoidosis — a condition causing inflammatory granulomas in the lungs, lymph nodes, and other organs. Elevated ACE levels are commonly seen in active sarcoidosis. Results available within 5–7 days.

Overview

The ACE (Angiotensin Converting Enzyme) Serum Test measures the level of angiotensin-converting enzyme in your blood. ACE is produced by cells called **epithelioid granulomas**, which are characteristic of **sarcoidosis** — a systemic inflammatory disease of unknown cause. While not diagnostic on its own, elevated ACE levels support the diagnosis when combined with clinical symptoms, imaging (like chest X-ray or CT), and biopsy findings. This test is also used to monitor disease activity and response to treatment. Results are typically available within 5–7 business days.

Why You Need This Test

• Support the diagnosis of sarcoidosis, especially when symptoms and imaging suggest granulomatous disease.
• Monitor disease activity and progression** in confirmed sarcoidosis patients.
• Evaluate unexplained chronic cough, shortness of breath, or fatigue.
• Assess lung, skin, or eye involvement linked to granulomatous inflammation.
• Rule out other causes of elevated ACE, such as leprosy, hyperparathyroidism, or Gaucher disease.
• Help differentiate sarcoidosis from tuberculosis or fungal infections.
• Available with home blood collection across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Shortness of breath or dry cough (lung involvement)
• Chest pain or tightness
• Red, swollen, or painful eyes (uveitis)
• Red or purple skin rashes (e.g., erythema nodosum)
• Swollen lymph nodes (especially in the chest)
• Joint pain, fatigue, or fever
• Abnormal liver function tests

Risk Factors

• Age 20–50 years — most common age group
• African or Scandinavian descent — higher prevalence
• Family history of sarcoidosis (genetic predisposition)
• Exposure to dust, mold, or chemicals (occupational risk)
• Autoimmune conditions or immune system dysregulation
• History of TB or fungal infections (differential diagnosis needed)

How the Test Works

Angiotensin-converting enzyme (ACE) is normally involved in blood pressure regulation. However, in sarcoidosis, activated macrophages within granulomas produce excess ACE, leading to elevated serum levels. The test measures ACE concentration in serum using enzymatic or immunoassay methods.

• Step 1 — Blood draw: a sample is collected from your arm vein into a red-top or gold-top serum tube.
• Step 2 — Clotting: blood is allowed to clot, then centrifuged to separate serum.
• Step 3 — Analysis: ACE activity or concentration is measured in the serum.
• Step 4 — Results: securely delivered within 5–7 business days.

This test is a valuable tool in evaluating granulomatous diseases, especially sarcoidosis.

Sample Type

• We take: Blood sample for serum (no anticoagulant)
• Container: Red-top (plain) or Gold-top (SST) serum separator tube
• Volume: 3–5 mL of blood
• How it’s collected: venous blood drawn by certified phlebotomist
• Processing: serum must be separated within 2 hours of collection
• Note: hemolyzed or lipemic samples may affect accuracy

Risks & Safety

• Minimal risk — slight pain, bruising, or dizziness during blood draw.
• No fasting required unless other tests are being done simultaneously.
• Safe for adults and older children.
• No side effects from the test itself.

Result Interpretation

Normal Range

• Adults: 8–52 U/L (lab-dependent; may vary by method and age)
• Levels are naturally higher in children and young adults

Elevated ACE Levels

• May indicate:
  • Sarcoidosis (especially active or widespread disease)
  • Leprosy (particularly lepromatous type)
  • Hyperparathyroidism
  • Gaucher disease or other lysosomal storage disorders
  • Diabetes mellitus (mild elevation)
  • Thyroid disorders (e.g., hyperthyroidism)

Normal or Low Levels

• Does not rule out sarcoidosis — some patients have normal ACE despite active disease.
• May suggest inactive or chronic disease.
• Low levels can occur with ACE inhibitor medications.

Consequences if Untreated

• Lung fibrosis leading to permanent breathing difficulties.
• Heart involvement (cardiac sarcoidosis) causing arrhythmias or heart failure.
• Vision loss due to chronic uveitis.
• Liver or kidney damage from granulomatous inflammation.
• Neurological complications if sarcoid affects the nervous system.
• Chronic fatigue and reduced quality of life.

Factors Affecting Test Results

• Medications: ACE inhibitors (lower levels), corticosteroids (may reduce during treatment).
• Time of day: ACE levels are higher in the morning.
• Age: naturally higher in children and young adults.
• Season: levels may be higher in summer (sunlight/vitamin D effect).
• Smoking: may slightly reduce ACE levels.
• Other diseases: tuberculosis, fungal infections, lymphoma (can mimic sarcoidosis).

FAQs

What is the ACE test used for?

The ACE test helps support the diagnosis of sarcoidosis and monitor disease activity by measuring angiotensin-converting enzyme levels in the blood.

Do I need to fast?

Fasting is not required for the ACE test. However, if other blood tests are ordered, your doctor may advise fasting.

How is the sample collected?

A blood sample is drawn from your arm into a serum tube (red or gold top) — no anticoagulant used.

How long for results?

Results are typically available within 5–7 days after the lab receives your sample.

What is the price of the test?

The ACE (Angiotensin Converting Enzyme) Serum Test costs AED 250 in the UAE, including home collection and reporting.

Can ACE levels be normal in sarcoidosis?

Yes — about 10–20% of sarcoidosis patients have normal ACE levels, so it cannot be used alone to rule out the disease.

Can I get this test at home?

Yes — we offer free home blood collection in Dubai, Abu Dhabi, Sharjah, and all Emirates.

Limitations

• Not diagnostic alone — must be interpreted with clinical, radiological, and histological findings.
• ACE can be elevated in other granulomatous diseases (e.g., leprosy, TB).
• Some sarcoidosis patients have normal ACE levels despite active disease.
• Results vary between labs and testing methods.
• Medications like ACE inhibitors suppress enzyme activity.
• Long turnaround time (5–7 days) may delay clinical decisions.

Book Your ACE (Angiotensin Converting Enzyme) Test Today

Don’t ignore persistent lung, skin, or eye symptoms — get answers for possible sarcoidosis with accurate, lab-confirmed testing.

• Home Blood Collection Available (Across Dubai, Abu Dhabi, Sharjah & All Emirates)
• Results in 5–7 Days | Endocrinology & Immunology-Grade Testing
• Price: AED 250
• ✅ CLIA-Certified Labs | ISO-Accredited Analysis
• 🩸 Trained Phlebotomists | Safe & Comfortable Draw
• 🔒 Secure Digital Reports | Doctor-Ready Format

Acetylcholine Receptor Antibodies (AChRab) Test in Dubai and across the UAE to diagnose autoimmune neuromuscular disorders. This specialized blood test detects antibodies that attack acetylcholine receptors at the neuromuscular junction — a key marker for myasthenia gravis (MG), a condition causing muscle weakness and fatigue. Results available within 5–7 days.

Overview

The Acetylcholine Receptor Antibodies (AChRab) Test identifies the presence of autoantibodies that mistakenly target acetylcholine receptors in the body’s neuromuscular pathways. These antibodies disrupt nerve-to-muscle communication, leading to muscle weakness — especially in the eyes, face, throat, and limbs. This test is the gold standard for confirming myasthenia gravis (MG), a chronic but treatable autoimmune disorder. Results are typically available within 5–7 business days due to specialized laboratory processing.

Why You Need This Test

• Diagnose myasthenia gravis (MG) — a common cause of unexplained muscle weakness.
• Evaluate symptoms like drooping eyelids (ptosis), double vision (diplopia), or difficulty swallowing.
• Investigate progressive limb weakness that worsens with activity and improves with rest.
• Rule out autoimmune causes in patients with chronic fatigue or voice changes.
• Support diagnosis when edrophonium (Tensilon) test or EMG results are inconclusive.
• Monitor disease progression or treatment response in known MG patients.
• Available with home blood collection across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Drooping eyelids (ptosis) — often the first sign
• Double or blurred vision (diplopia)
• Difficulty speaking, chewing, or swallowing
• Weakness in arms, hands, legs, or neck that worsens with use
• Breathing difficulties in severe cases (myasthenic crisis)
• Fatigue that increases throughout the day

Risk Factors

• Women under 40 and men over 60 — most commonly affected age groups
• Autoimmune history — such as lupus, rheumatoid arthritis, or thyroid disease
• Thymus gland abnormalities — including thymoma or thymic hyperplasia
• Family history of autoimmune or neuromuscular disorders
• Viral infections or immune triggers preceding symptom onset
• Post-COVID or post-vaccination autoimmune reactions (rare)

How the Test Works

In myasthenia gravis, the immune system produces antibodies that block or destroy acetylcholine receptors, preventing muscles from receiving nerve signals. The AChRab test measures three types of antibodies: **binding**, **blocking**, and **modulating** — with binding antibodies being the most commonly detected.

• Step 1 — Appointment: schedule a lab visit or request home blood draw.
• Step 2 — Sample collection: a small blood sample is taken from your arm.
• Step 3 — Laboratory analysis: performed using radioimmunoprecipitation assay (RIPA) or ELISA methods.
• Step 4 — Results: securely delivered within 5–7 business days.

This test is essential for confirming myasthenia gravis and guiding treatment with immunosuppressants, IVIG, or thymectomy.

Sample Type

• We take: Venous blood sample (from the arm)
• Volume: 3–5 mL
• Container: serum separator tube (SST)
• Fasting: not required
• Special handling: serum must be separated promptly and stored at 2–8°C
• Note: hemolyzed or lipemic samples may interfere with accuracy

Risks & Safety

• Minimal risk — slight pain or bruising at the needle site.
• No recovery time needed; resume normal activities immediately.
• Safe for adults and older children.
• Performed by trained phlebotomists using sterile, single-use equipment.
• No side effects from the test itself.

Result Interpretation

Normal Range

• Negative: < 0.05 nmol/L (binding antibodies)
• Results may vary slightly depending on method and lab reference values.

Positive Results

• Typically indicate:
  • Myasthenia gravis (MG) — present in ~85% of generalized cases
  • Ocular myasthenia — lower positivity rate (~50%)
  • Thymoma-associated MG — often high antibody levels

Negative but Symptomatic?

• May suggest:
  • Seronegative myasthenia gravis — test for MuSK or LRP4 antibodies
  • Other neuromuscular disorders — e.g., Lambert-Eaton syndrome, ALS
  • Early-stage disease — retesting may be needed later

Consequences if Untreated

• Progressive muscle weakness affecting mobility, speech, and swallowing.
• Myasthenic crisis — life-threatening respiratory failure requiring ICU care.
• Chronic fatigue and reduced quality of life.
• Increased risk of aspiration pneumonia due to swallowing difficulties.
• Long-term disability without proper diagnosis and treatment.

Factors Affecting Test Results

• Recent immunotherapies: plasmapheresis, IVIG, or high-dose steroids may lower antibody levels.
• Thymectomy: surgery to remove the thymus can reduce antibody production over time.
• Disease duration: early MG may not yet show detectable antibodies.
• Antibody type: MuSK or LRP4 antibodies not detected by standard AChRab test.
• Medications: cholinesterase inhibitors (e.g., pyridostigmine) do not affect antibody levels.
• Lab methodology: sensitivity varies between assays — use of RIPA is considered most accurate.

FAQs

Limitations

• Not all myasthenia gravis patients test positive — seronegative MG requires additional antibody testing (MuSK, LRP4).
• Results take longer (5–7 days) due to specialized lab techniques.
• Does not reflect disease severity — antibody levels don’t always correlate with symptoms.
• False negatives possible in ocular or early-stage MG.
• Not used for routine screening — only for symptomatic patients.

Book Your AChRab Test Today

Don’t ignore unexplained muscle weakness or drooping eyelids — get an accurate diagnosis for myasthenia gravis and start effective treatment.

• Home Blood Collection Available (Dubai, Abu Dhabi, Sharjah, Ajman, RAK, Umm Al Quwain, Fujairah)
• Precise, Lab-Confirmed Results in 5–7 Days
• Price: AED 450
• ✅ Accredited Labs | Neurology-Grade Testing
• 🩸 Expert Phlebotomists | Comfortable Draw
• 🔒 Confidential & Secure Reporting

Acetylcholine Receptor Antibody Test in Dubai and across the UAE to diagnose autoimmune neuromuscular disorders, particularly myasthenia gravis (MG). This blood test detects antibodies that attack acetylcholine receptors at the neuromuscular junction, disrupting nerve-to-muscle communication. Essential for confirming the cause of unexplained muscle weakness, this test delivers results within 4–6 days.

Overview

The Acetylcholine Receptor (AChR) Antibody Test measures the presence and level of autoantibodies that target acetylcholine receptors — crucial proteins involved in muscle contraction. These antibodies are a hallmark of myasthenia gravis (MG), a chronic autoimmune condition causing fluctuating muscle weakness. The test is highly specific and plays a key role in differentiating MG from other neurological or muscular disorders. Results are typically available within 4–6 business days after blood sample collection.

Why You Need This Test

• Confirm diagnosis of myasthenia gravis in patients with unexplained muscle weakness.
• Evaluate symptoms like drooping eyelids (ptosis), double vision (diplopia), or difficulty swallowing.
• Differentiate MG from other neuromuscular conditions such as Lambert-Eaton syndrome or ALS.
• Support diagnosis in patients with thymoma or thymic abnormalities.
• Monitor disease progression or treatment response in known MG patients.
• Rule out autoimmune causes in cases of fatigable weakness worsening with activity.
• Available with home blood collection across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Drooping eyelids (ptosis) — often worse in the evening
• Double or blurred vision (diplopia) that comes and goes
• Difficulty speaking, chewing, or swallowing
• Weakness in arms, hands, legs, or neck muscles
• Breathing difficulties during flare-ups (myasthenic crisis)
• Fatigue that worsens with use and improves with rest

Risk Factors

• Women under 40 and men over 60 are at higher risk
• Autoimmune disorders (e.g., lupus, rheumatoid arthritis, thyroid disease)
• Thymus gland abnormalities — including thymoma or hyperplasia
• Family history of autoimmune or neuromuscular diseases
• Viral infections or immune triggers preceding symptom onset
• Recent surgery or stress may unmask latent disease

How the Test Works

The AChR antibody test detects autoantibodies that block or destroy acetylcholine receptors at the neuromuscular junction — the point where nerves signal muscles to contract. When these antibodies are present, nerve signals fail to trigger proper muscle response, leading to weakness.

• Step 1 — Appointment: schedule a convenient time for blood draw at home or clinic.
• Step 2 — Sample collection: a trained phlebotomist collects a small blood sample (no fasting required).
• Step 3 — Processing: serum is isolated and sent to a certified immunology lab.
• Step 4 — Testing: performed using radioimmunoprecipitation assay (RIPA) for high accuracy.
• Step 5 — Results: securely delivered within 4–6 business days.

This test is critical for early diagnosis and effective management of myasthenia gravis.

Sample Type

• We take: Blood (serum sample)
• Volume: 5–10 mL of venous blood
• Container: red-top or serum separator tube (SST)
• How it’s collected: standard venipuncture by a certified phlebotomist
• Storage: serum must be separated within 2 hours and kept refrigerated (2–8°C)
• Note: hemolyzed or lipemic samples may affect test accuracy

Risks & Safety

• Minimal risk — standard blood draw with brief discomfort.
• No side effects in most individuals.
• Slight bruising or soreness at the needle site may occur.
• Safe for adults and older children.
• No recovery time needed — resume normal activities immediately.

Result Interpretation

Normal Range

• Negative: < 0.05 nmol/L (lab-dependent)
• Levels below cutoff indicate no detectable AChR antibodies

Positive Results

• Positive (elevated antibodies):
  • Strongly supports diagnosis of myasthenia gravis (found in ~85% of generalized MG cases)
  • Higher titers often correlate with disease severity
  • May be present in patients with thymoma even without symptoms

Negative but Symptomatic?

• Consider anti-MuSK (muscle-specific kinase) or anti-LRP4 antibody testing — some patients are AChR-negative but still have autoimmune MG.

Consequences if Untreated

• Progressive muscle weakness affecting mobility and daily function.
• Myasthenic crisis: life-threatening respiratory failure requiring ICU care.
• Dysphagia and aspiration pneumonia due to weakened throat muscles.
• Chronic fatigue and reduced quality of life.
• Increased risk of falls, injuries, and hospitalization.

Factors Affecting Test Results

• Recent plasmapheresis or IVIG therapy: may lower antibody levels temporarily.
• Immunosuppressive medications: steroids, azathioprine, or mycophenolate may reduce titers.
• Thymectomy: antibody levels may decline post-surgery.
• Test sensitivity: up to 15% of generalized MG patients are AChR antibody-negative.
• Lab methodology: RIPA-based tests are most accurate; ELISA may have false positives.

FAQs

Limitations

• Not all myasthenia gravis patients test positive — seronegative MG exists.
• Must be interpreted alongside clinical symptoms, EMG, and imaging (e.g., chest CT for thymoma).
• Does not measure disease activity perfectly — some with high titers are stable, others with low titers may worsen.
• Not useful for monitoring in all cases — clinical assessment remains key.
• False negatives possible if tested too early or after immunotherapy.

Book Your Acetylcholine Receptor Antibody Test Today

Don’t ignore unexplained muscle weakness — get a definitive answer for myasthenia gravis and start effective treatment.

• Home Blood Collection Available (Across Dubai, Abu Dhabi, Sharjah & All Emirates)
• Accurate, Lab-Certified Results in 4–6 Days
• Price: AED 350
• ✅ CLIA/NABL Accredited Labs | Neuroimmunology Testing
• 🩸 Pain-Free Sample Collection | Expert Phlebotomists
• 🔒 Confidential Reporting | PDF Report with Reference Values

Acetylcholine Receptor Binding Antibody (AChR), Serum Test in Dubai and across the UAE to help diagnose myasthenia gravis (MG), a chronic autoimmune neuromuscular disorder. This blood test detects antibodies that attack acetylcholine receptors at the neuromuscular junction, disrupting nerve-to-muscle communication. Highly specific and essential for confirming autoimmune MG, results are available within 5–7 days.

Overview

The Acetylcholine Receptor (AChR) Binding Antibody test measures the presence and level of autoantibodies in the blood that target acetylcholine receptors on muscle cells. These antibodies block or destroy receptors, impairing muscle contraction and leading to progressive weakness — hallmark signs of myasthenia gravis (MG). This test is the most specific blood test for diagnosing generalized MG, with over 80% positivity in adults with the condition. Results are typically available within 5–7 business days.

Why You Need This Test

• Confirm a suspected diagnosis of myasthenia gravis in patients with fluctuating muscle weakness.
• Evaluate unexplained drooping eyelids (ptosis), double vision (diplopia), or facial weakness.
• Assess difficulty swallowing, slurred speech, or limb weakness that worsens with activity.
• Differentiate MG from other neurological conditions like Lambert-Eaton syndrome, ALS, or multiple sclerosis.
• Support diagnosis in patients with thymoma (thymus tumor), which is strongly linked to AChR antibodies.
• Guide treatment decisions involving immunosuppressive therapy or thymectomy.
• Available with home blood collection service across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms of Myasthenia Gravis

• Drooping eyelids (ptosis) — often one-sided or variable
• Double or blurred vision (diplopia)
• Difficulty swallowing (dysphagia) or choking on liquids
• Slurred speech (dysarthria) that worsens with talking
• Weakness in arms, hands, legs, or neck muscles
• Facial muscle weakness causing expressionless appearance
• Breathing difficulties in severe cases (myasthenic crisis)
• Symptoms typically worsen with activity and improve with rest

Risk Factors

• Women under 40 and men over 60 are most commonly affected
• Autoimmune disorders (e.g., lupus, rheumatoid arthritis, thyroid disease)
• Thymus abnormalities — including thymic hyperplasia or thymoma
• Family history of autoimmune diseases
• Recent infections or immune triggers may precede symptom onset
• Medications like penicillamine or checkpoint inhibitors (rarely)

How the Test Works

In myasthenia gravis, the immune system mistakenly produces antibodies against acetylcholine receptors at the neuromuscular junction — the site where nerves signal muscles to contract. The AChR binding antibody test uses radioimmunoprecipitation to detect these antibodies in serum. When present, they confirm an autoimmune basis for muscle weakness.

• Step 1 — Appointment: schedule a simple blood draw at home or at a certified lab.
• Step 2 — Sample collection: a trained phlebotomist collects a small blood sample (serum).
• Step 3 — Processing: serum is separated and tested using high-sensitivity immunoassay methods.
• Step 4 — Analysis: labs measure antibody levels targeting the AChR binding site.
• Step 5 — Results: securely delivered within 5–7 business days.

This test is a cornerstone in diagnosing autoimmune myasthenia gravis.

Sample Type

• We take: Venous blood sample (serum)
• Volume: 2–3 mL of serum (typically one red-top or serum separator tube)
• Container: clotting tube (SST) — no anticoagulant
• How it’s collected: standard venipuncture by certified phlebotomist
• Storage: serum must be separated within 2 hours and kept refrigerated (2–8°C) or frozen if delayed
• Note: hemolyzed or lipemic samples may affect accuracy and require recollection

Risks & Safety

• Minimal risk — standard blood draw with slight pain or bruising at the site.
• No fasting or special prep required for this test.
• Safe for adults and older children — no contraindications.
• No side effects from the test itself.

Result Interpretation

Normal Range

• Negative: < 0.02 nmol/L (lab-dependent)
• Levels below cutoff indicate no detectable AChR binding antibodies

Positive Result

• Interpretation: Elevated levels confirm autoimmune myasthenia gravis
  • Mild elevation: early or mild disease
  • Moderate to high: correlates with disease severity in many cases
• Note: ~80–90% of patients with generalized MG test positive; ~50% with ocular MG

Negative Result

• Does not rule out MG — consider testing for muscle-specific kinase (MuSK) or LRP4 antibodies.
• May indicate seronegative myasthenia gravis.
• Clinical evaluation and electrodiagnostic tests (e.g., repetitive nerve stimulation) remain essential.

Consequences if Untreated

• Progressive muscle weakness affecting swallowing, speech, and mobility.
• Myasthenic crisis — life-threatening respiratory failure requiring ICU care.
• Chronic fatigue and disability impacting quality of life.
• Increased risk of pneumonia due to impaired cough reflex.
• Thymoma progression if associated tumor is undiagnosed.

Factors Affecting Test Results

• Immunosuppressive therapy: steroids, azathioprine, or IVIG may lower antibody levels.
• Plasmapheresis or plasma exchange: temporarily reduces antibody concentration.
• Timing of sample: early disease may yield false-negative results.
• Test sensitivity: some labs may miss low-titer cases — use of reference labs recommended.
• Other autoimmune conditions: rare false positives in lupus or autoimmune hepatitis.

FAQs

Limitations

• Negative result does not rule out MG — up to 20% of generalized and 50% of ocular MG cases are seronegative.
• Requires correlation with clinical symptoms, EMG, and imaging (chest CT for thymoma).
• Not useful for monitoring disease activity in all patients — antibody levels don’t always correlate with symptoms.
• Specialized test — must be performed in experienced reference laboratories.
• Turnaround time is longer than routine blood tests (5–7 days).

Book Your AChR Antibody Test Today

Suspect myasthenia gravis? Get a definitive answer with accurate antibody testing.

• Home Blood Collection Available in Dubai, Abu Dhabi, Sharjah & All Emirates
• Precise, Reliable Results in 5–7 Days
• Price: AED 500
• ✅ Accredited Labs | Specialized Neuroimmunology Testing
• 🩸 Certified Phlebotomists | Comfortable at-Home Service
• 🔒 Confidential Reporting | PDF Results Online

Acetylcholinesterase – Amniotic Fluid Test in Dubai and across the UAE to assess fetal neural tube development and detect serious congenital abnormalities such as spina bifida and anencephaly. This specialized test analyzes amniotic fluid for the presence of acetylcholinesterase, a key enzyme linked to open neural tube defects. Results available within 15 days.

Overview

The Acetylcholinesterase (AChE) – Amniotic Fluid Test is a critical prenatal diagnostic tool used to confirm the presence of **open neural tube defects (NTDs)** in the developing fetus. When the spinal cord or brain fails to close properly during early pregnancy, proteins and enzymes like acetylcholinesterase leak into the amniotic fluid. This test detects that enzyme, providing definitive evidence beyond what ultrasound or maternal serum AFP can show. It is typically performed after an abnormal **maternal serum alpha-fetoprotein (MSAFP)** result or suspicious fetal ultrasound findings. Results are processed in specialized labs and available within 15 business days.

Why You Need This Test

• Confirm open neural tube defects such as spina bifida or anencephaly.
• Follow-up after elevated maternal serum AFP (MSAFP) levels.
• Investigate abnormal fetal anatomy seen on level II ultrasound or anomaly scan.
• Differentiate between open and closed NTDs — only open defects release AChE into amniotic fluid.
• Support informed decision-making during high-risk pregnancies.
• Essential for pregnancies with family history of NTDs or maternal folic acid deficiency.
• Performed using amniotic fluid obtained via amniocentesis, available at accredited centers across Dubai, Abu Dhabi, and the UAE.

Symptoms & Risk Factors

Fetal Indicators (Detected via Screening)

• Elevated maternal AFP levels in second-trimester screening
• Abnormal ultrasound findings: “lemon sign” (skull shape), “banana sign” (cerebellum), spinal irregularities
• Polyhydramnios (excess amniotic fluid)
• Low fetal position or breech presentation in later stages

Maternal & Environmental Risk Factors

• Inadequate folic acid intake before and during early pregnancy
• Family history of neural tube defects
• Pre-gestational diabetes (poorly controlled)
• Obesity (BMI >30)
• Use of certain anti-seizure medications (e.g., valproic acid, carbamazepine)
• Hyperthermia (high fever or sauna use) in first trimester
• Exposure to environmental toxins or pesticides

How the Test Works

Acetylcholinesterase is an enzyme normally found in nerve tissue. In cases of **open neural tube defects**, fetal neural tissue is exposed to amniotic fluid, allowing AChE to leak from the central nervous system. Unlike alpha-fetoprotein (AFP), which can be elevated for other reasons, **acetylcholinesterase is highly specific for open NTDs**.

• Step 1 — Amniocentesis: performed by a perinatologist between 15–20 weeks of gestation; a small amount of amniotic fluid is extracted using ultrasound guidance.
• Step 2 — Sample handling: fluid is collected in a sterile container, kept cool, and sent immediately to the lab.
• Step 3 — Laboratory analysis: gel electrophoresis or immunoassay detects the presence of acetylcholinesterase bands.
• Step 4 — Interpretation: a positive AChE band confirms an open neural tube defect.
• Step 5 — Results: detailed report issued within 15 business days.

This test provides crucial diagnostic clarity when ultrasound and blood tests raise concerns.

Sample Type

• We take: Amniotic fluid (minimum 5–10 mL recommended)
• Collection method: transabdominal amniocentesis under ultrasound guidance
• Container: sterile, DNA/RNA-free tube (no preservatives)
• Storage: refrigerated (2–8°C) during transport; no freezing
• Labeling: must include maternal name, gestational age, and date/time of collection
• Note: hemolyzed or contaminated samples may not be analyzable

Risks & Safety

• Procedure risk: amniocentesis carries a small risk of miscarriage (0.1–0.3%).
• Minor discomfort during needle insertion; cramping may occur afterward.
• Leakage of fluid or spotting is rare but possible.
• Infection risk is very low with sterile technique.
• No risk to the baby from the lab test itself — analysis is performed on extracted fluid.
• Recommended only when clinical indications justify the procedure.

Result Interpretation

Normal Result

• Negative for acetylcholinesterase: no enzyme band detected
• Suggests absence of **open neural tube defect**
• May still require correlation with ultrasound and AFP levels

Abnormal Result

• Positive for acetylcholinesterase: clear enzyme band present on electrophoresis
• Highly indicative of an **open neural tube defect**, such as:
  • Spina bifida (myelomeningocele)
  • Anencephaly
  • Encephalocele
• False positives are rare; confirmation with imaging is standard

Borderline or Inconclusive

• Faint or uncertain bands may require repeat analysis or expert review
• Correlation with detailed anomaly scan is essential

Consequences if Undiagnosed

• Spina bifida: can lead to paralysis, bladder/bowel dysfunction, hydrocephalus, and lifelong disability.
• Anencephaly: fatal condition; babies are stillborn or die shortly after birth.
• Lack of prenatal planning: missed opportunity for specialized delivery, neonatal surgery, or informed choices.
• Emotional and psychological impact on families due to unexpected diagnosis at birth.
• Increased risk of preterm birth or cesarean delivery due to fetal malposition.

Factors Affecting Test Results

• Gestational age: testing too early (<15 weeks) may yield false negatives.
• Blood contamination: maternal blood in sample can interfere with analysis.
• Improper storage: delayed refrigeration or freezing damages enzymes.
• Previous intrauterine procedures: such as fetal blood sampling or transfusion.
• Multiple gestation: increases complexity; fluid must be clearly identified per sac.
• Open abdominal wall defects: e.g., gastroschisis or omphalocele, may rarely cause AChE positivity.

FAQs

Limitations

• Only detects open neural tube defects — closed defects (e.g., spina bifida occulta) do not release AChE.
• Requires invasive procedure (amniocentesis) with small miscarriage risk.
• Not a screening test — used only after abnormal initial findings.
• Long turnaround time (15 days) may delay decision-making.
• Results must be interpreted alongside ultrasound, AFP, and clinical context.
• Not widely available — requires specialized lab processing and expertise.

Book the Acetylcholinesterase – Amniotic Fluid Test Today

Get clarity after an abnormal prenatal screening — understand your baby’s health with accurate, lab-confirmed diagnosis.

• Available at Accredited Fetal Medicine Centers in Dubai, Abu Dhabi & Across UAE
• Specialized Lab Analysis for Open Neural Tube Defects
• Price: AED 410 (Amniocentesis procedure billed separately)
• ✅ Expert Interpretation | CLIA-Aligned Labs
• 🔬 High Specificity for Spina Bifida & Anencephaly
• 🔒 Confidential Reporting | Secure Data Handling
• 🕒 Results in 15 Days

Acetylcholinesterase (RBC) OPC Poisoning Blood Test in Dubai and across the UAE to detect organophosphate or carbamate pesticide exposure. This critical test measures the activity of acetylcholinesterase enzyme in red blood cells, which is severely reduced in cases of OPC (Organophosphate and Carbamate) poisoning — a life-threatening condition. Results available within 7–10 days. Test price: AED 350, including sample collection and certified lab analysis.

Overview

The Acetylcholinesterase (RBC) Test evaluates the functional activity of the acetylcholinesterase enzyme in red blood cells, which plays a vital role in nerve signal transmission. Organophosphate (OP) and carbamate pesticides — commonly found in insecticides and agricultural chemicals — inhibit this enzyme, leading to toxic accumulation of acetylcholine and severe neurological symptoms. This test is essential for diagnosing and monitoring OPC poisoning, especially in occupational exposure, accidental ingestion, or suicidal intent cases. Results are typically available within 7–10 business days. The complete test package costs AED 350 across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Why You Need This Test

• Confirm organophosphate or carbamate poisoning in suspected cases.
• Evaluate individuals with acute neurological symptoms after chemical exposure.
• Monitor pesticide handlers, farmers, or industrial workers for chronic exposure.
• Support emergency diagnosis in intoxication cases with respiratory distress or muscle weakness.
• Assess severity and guide treatment with antidotes like atropine or pralidoxime.
• Used in hospitals and toxicology units for critical care decision-making.
• Available with standard blood draw at clinic or home — only AED 350.

Symptoms & Risk Factors

Common Symptoms of OPC Poisoning

• Excessive salivation, sweating, and tearing (SLUDGE syndrome)
• Nausea, vomiting, abdominal cramps, and diarrhea
• Pinpoint pupils (miosis) and blurred vision
• Muscle twitching, weakness, or paralysis
• Breathing difficulties or respiratory failure
• Anxiety, confusion, seizures, or coma in severe cases

Risk Factors

• Occupational exposure to pesticides (farmers, sprayers, agricultural workers)
• Ingestion of contaminated food or water
• Intentional poisoning (suicidal or criminal)
• Poor use of protective gear during pesticide handling
• Living in rural or agricultural areas with high pesticide use
• Children exposed to chemical spills or contaminated clothing

How the Test Works

Organophosphates and carbamates irreversibly (or temporarily) inhibit acetylcholinesterase, the enzyme that breaks down acetylcholine in nerve junctions. When this enzyme is suppressed, acetylcholine builds up, causing continuous nerve stimulation and life-threatening symptoms.

• Step 1 — Sample Collection: a simple blood draw from the arm (venipuncture).
• Step 2 — Analysis: lab measures the enzyme activity in red blood cells (RBC cholinesterase), which reflects long-term inhibition.
• Step 3 — Interpretation: compared to baseline or reference ranges.
• Step 4 — Reporting: results delivered securely within 7–10 business days.

This test is more reliable than plasma cholinesterase for assessing chronic or past exposure, as RBC enzyme levels reflect inhibition over the lifespan of red blood cells (~120 days).

Sample Type

• We take: Whole blood sample (EDTA or heparin tube)
• Volume: 3–5 mL
• Container: lavender-top (EDTA) or green-top (heparin) tube
• How it’s collected: standard venous blood draw from the arm
• Storage: sample must be kept at room temperature and processed within 6–12 hours
• Note: hemolyzed or delayed samples may affect accuracy

Risks & Safety

• Minimal risk — standard blood draw with slight pain or bruising at the site.
• No fasting required.
• Safe for adults and children in emergency or occupational settings.
• Crucial for timely diagnosis and treatment in poisoning cases.

Result Interpretation

Normal Range

• Normal: Varies by lab, but typically 2.5–6.5 U/mL (or as per reference)
• Baseline levels may be established for high-risk occupational groups

Low Levels (Reduced Activity)

• Indicates:
  • Organophosphate or carbamate poisoning
  • Severity correlates with enzyme suppression (e.g., >50% drop = severe)
  • Chronic occupational exposure (even without symptoms)

Normal or Rising Levels After Treatment

• Suggests:
  • Effective antidote therapy (pralidoxime helps regenerate enzyme)
  • Recovery phase — new RBCs restore enzyme activity over weeks

Consequences if Untreated

• Respiratory failure due to paralysis of respiratory muscles.
• Seizures, coma, or death in severe poisoning.
• Intermediate syndrome (muscle weakness 24–96 hrs post-exposure).
• Long-term neurological damage (memory loss, neuropathy).
• Delayed neuropathy (rare, weeks after exposure).

Factors Affecting Test Results

• Timing of sample: enzyme levels drop rapidly after exposure.
• Recent antidote use: pralidoxime may not reverse RBC enzyme inhibition.
• Hemolysis: can interfere with enzyme measurement.
• Genetic variants: some individuals have naturally lower cholinesterase.
• Other conditions: liver disease, malnutrition, pregnancy may affect levels.
• Repeat testing: recommended to monitor recovery or re-exposure.

FAQs

Limitations

• Results may not be immediately available in emergencies (7–10 days turnaround).
• Does not identify the specific toxin — clinical history is essential.
• Normal results don’t rule out carbamate poisoning (enzyme inhibition may be transient).
• Requires comparison with baseline or pre-exposure levels for accurate interpretation.
• Not widely available in all labs — requires specialized toxicology testing.

Book Your Acetylcholinesterase (RBC) OPC Poisoning Blood Test Today

Protect yourself or a loved one from pesticide toxicity — get a definitive diagnosis with accurate lab testing.

• Home or Clinic Blood Collection Available (Dubai, Abu Dhabi, Sharjah & all Emirates)
• Fast, Accurate, Confidential Results in 7–10 Days
• Price: AED 350
• ✅ Certified Labs | Toxicology-Grade Testing
• 🩸 Trained Phlebotomists | Safe & Hygienic
• 🔒 Secure Reporting | Doctor-Ready Results

Acetylcholinesterase (OPC Poisoning) Plasma Test in Dubai and across the UAE to detect organophosphate or carbamate pesticide exposure. This critical test measures enzyme activity in the blood, helping confirm poisoning and guide emergency treatment. It is essential for patients with suspected pesticide ingestion, occupational exposure, or unexplained neurological symptoms. Results available within 7–10 days.

Overview

The Acetylcholinesterase Plasma Test measures the activity of acetylcholinesterase — an enzyme vital for normal nerve function — in the bloodstream. Organophosphate (OP) and carbamate (OPC) compounds, commonly found in pesticides and insecticides, inhibit this enzyme, leading to toxic accumulation of acetylcholine and life-threatening neurological effects. This test helps confirm exposure, assess severity, and monitor recovery. While not immediate, it plays a crucial role in diagnosing chronic or delayed cases. Results are typically available within 7–10 business days.

Why You Need This Test

• Confirm organophosphate or carbamate poisoning in symptomatic individuals.
• Evaluate patients with unexplained muscle weakness, twitching, or respiratory distress.
• Assess individuals with known or suspected pesticide exposure (occupational or accidental).
• Support diagnosis in cases of intentional ingestion (suicidal attempts).
• Monitor recovery and enzyme regeneration during treatment.
• Used in emergency medicine, toxicology, and occupational health settings.
• Available for urgent testing in Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms (SLUDGE Syndrome)

• Salivation, Lacrimation (excessive tearing)
• Urination, Defecation (increased frequency)
• Gastrointestinal cramps, Emesis (vomiting)
• Bradycardia (slow heart rate), hypotension
• Muscle fasciculations, weakness, or paralysis
• Respiratory distress or difficulty breathing
• Anxiety, confusion, seizures, or coma in severe cases

Risk Factors

• Agricultural workers handling pesticides
• Exposure to insecticides (e.g., malathion, parathion, chlorpyrifos)
• Ingestion of contaminated food or water
• Intentional self-poisoning (common in certain regions)
• Poor use of protective equipment during spraying
• Living in rural or farming areas with high pesticide use

How the Test Works

Organophosphates and carbamates irreversibly (or temporarily) inhibit acetylcholinesterase, the enzyme that breaks down acetylcholine at nerve junctions. Excess acetylcholine causes overstimulation of muscles and glands. The plasma acetylcholinesterase test measures enzyme activity — significantly reduced levels confirm poisoning.

• Step 1 — Blood draw: a healthcare professional collects a blood sample from a vein.
• Step 2 — Sample handling: plasma is separated and preserved for analysis.
• Step 3 — Laboratory testing: enzyme activity is measured using spectrophotometric methods.
• Step 4 — Interpretation: results compared to normal reference ranges.
• Step 5 — Results: securely delivered within 7–10 business days.

This test is vital for confirming poisoning when clinical signs are unclear or delayed.

Sample Type

• We take: Venous blood sample (plasma)
• Volume: 3–5 mL collected in a green-top (heparin) or pink-top (EDTA) tube
• Processing: plasma must be separated within 2 hours of collection
• Storage: refrigerated (2–8°C) or frozen (-20°C) if delayed
• Note: hemolyzed or improperly stored samples may affect accuracy

Risks & Safety

• Minimal risk — standard blood draw with slight pain or bruising at the site.
• No fasting or special prep required.
• Safe for adults and children — especially critical in pediatric poisoning cases.
• Test is non-invasive beyond the needle prick.

Result Interpretation

Normal Range

• Normal: Varies by lab and method (typically 5,000–12,000 U/L)
• Baseline levels differ between individuals — serial testing is more informative

Reduced Activity

• Mild reduction (50–70% of normal): possible early or mild exposure
• Moderate (30–50%): consistent with clinical poisoning
• Severe (<30%): indicates significant poisoning, correlates with symptom severity
• Near-zero: life-threatening inhibition, requires urgent treatment

Important Notes

• Plasma cholinesterase (PChE) declines faster than red blood cell (RBC) acetylcholinesterase.
• RBC AChE reflects tissue enzyme activity and recovers more slowly.
• Testing both provides a fuller clinical picture.

Consequences if Untreated

• Respiratory failure due to paralysis of respiratory muscles.
• Seizures or coma from CNS overstimulation.
• Intermediate syndrome (muscle weakness 24–96 hrs post-exposure).
• Long-term neurological damage or cognitive deficits.
• Death if not treated promptly with atropine and oximes.

Factors Affecting Test Results

• Time since exposure: enzyme levels drop rapidly after poisoning.
• Antidote treatment: atropine doesn’t affect enzyme levels, but oximes may help restore activity.
• Genetic variations: some individuals have naturally lower cholinesterase levels.
• Liver disease: reduces plasma enzyme synthesis.
• Pregnancy: may lower baseline levels.
• Chronic low-level exposure: can cause gradual enzyme suppression.

FAQs

Limitations

• Turnaround time is 7–10 days — not suitable for real-time emergency decisions.
• Results must be interpreted alongside clinical symptoms and exposure history.
• Does not identify the specific toxin — only confirms enzyme inhibition.
• Plasma levels may recover faster than RBC levels — consider both for monitoring.
• Baseline levels vary — serial testing is more useful than a single value.

Book Your Acetylcholinesterase (OPC Poisoning) Test Today

Early detection saves lives — get accurate confirmation of pesticide exposure for timely treatment.

• Blood Collection Available at Home (Across Dubai, Abu Dhabi, Sharjah & All Emirates)
• Detailed Results in 7–10 Days | Critical for Diagnosis & Follow-Up
• Price: AED 300
• ✅ Accredited Labs | Toxicology & Emergency Medicine Certified
• 💉 Professional Phlebotomist | Safe & Hygienic Collection
• 🔒 Confidential Reporting | Doctor-Ready Results

The Adenosine Deaminase (ADA) test measures the level of the enzyme adenosine deaminase in the blood. This test is primarily used to help diagnose and monitor conditions such as tuberculosis and other infections, as well as certain types of cancer, making it a crucial tool in clinical diagnostics.

The AIH PLUS test measures various autoantibodies including ANCA, SLA, ANA, SMA, AMA, LKM-1, and TOTAL IGG in serum. This comprehensive panel aids in the diagnosis and monitoring of autoimmune hepatitis and related conditions, providing crucial insights into the immune response.

The Allergy - Almond f20 test measures various health markers related to almond allergies. This test is essential for individuals who suspect an allergy to almonds, providing crucial information for diagnosis and management.

The Allergy - Aspergillus fumigatus (m3) test measures various health markers related to allergic reactions to the Aspergillus fumigatus fungus. This test is essential for diagnosing and monitoring allergic conditions associated with mold exposure.

The Allergy - Cabbage f216 test evaluates various health markers related to allergic reactions to cabbage. This test is essential for identifying sensitivities and managing allergic conditions effectively.

The Allergy - Chocolate f105 test measures various health markers related to chocolate allergies. This test helps identify specific allergic responses and can guide dietary choices for those with sensitivities.

The Allergy - Cucumber f244 test measures various health markers related to allergic reactions to cucumbers. This test is essential for individuals experiencing allergy symptoms and helps in identifying specific sensitivities.

The Allergy - Glycyphagus domesticus d73 test measures various health markers related to allergic reactions. This test is essential for identifying sensitivities to specific allergens, aiding in the diagnosis and management of allergic conditions.

The Allergy-Grape test measures various health markers related to allergic reactions to grapes. This test is essential for individuals who suspect they may have a grape allergy and helps in diagnosing and managing allergic conditions effectively.

The Allergy - June Grass g8 test measures various health markers related to allergic reactions to June grass pollen. This test is essential for identifying sensitivities and managing allergy symptoms effectively.

The Allergy - Lemon f208 test measures various health markers related to allergic reactions to lemon. This test helps identify sensitivities and can guide dietary choices for individuals experiencing allergic symptoms.

The Allergy Acarus siro test measures various health markers related to allergic reactions. This test is crucial for identifying sensitivities to specific allergens, helping in the diagnosis and management of allergic conditions.

The Allergy to Aubergine (Eggplant) Test measures various health markers related to allergic reactions to eggplant. This test is essential for individuals experiencing allergy symptoms after consuming eggplant, helping to identify potential sensitivities.

The Allergy to Cheddar Cheese Test (f81) measures various health markers related to allergic reactions to cheddar cheese. This test is essential for individuals who suspect they have a cheese allergy, helping to identify specific sensitivities.

The Allergy to Chocolate Cocoa test measures various health markers to assess potential allergic reactions to chocolate and cocoa products. This test is essential for individuals experiencing symptoms related to chocolate consumption, helping to identify specific sensitivities.

The Allergy to Cladosporium herbarum m2 test measures various health markers related to allergic reactions to the Cladosporium herbarum fungus. This test is essential for diagnosing and managing allergies, providing valuable insights into your immune response.

The Allergy to Cow Dander test measures various health markers related to allergic reactions to cow dander. This test is essential for individuals experiencing allergy symptoms potentially linked to exposure to cows or their environment.

The Allergy to Horse Dander Test e3 measures various health markers related to allergic reactions to horse dander. This test is essential for individuals experiencing allergy symptoms and helps in diagnosing and managing allergic conditions effectively.

The Allergy to Lepidoglyphus destructor (d71) test measures various health markers related to allergic reactions to the Lepidoglyphus destructor mite. This test is essential for diagnosing and managing allergies, providing insights into the immune response triggered by this specific allergen.

The Allergy to Wool Test (K20) is designed to measure various health markers related to wool allergies. This test helps identify specific allergic reactions that may be triggered by exposure to wool, providing essential information for effective management of allergy symptoms.

The Allergy-Apple f49 test measures various health markers related to apple allergies. This test is essential for identifying allergic reactions to apples and can help in managing dietary restrictions effectively.

The Allergy-Bahia g17 test measures various health markers related to allergic reactions. It provides valuable insights into your immune response and helps identify potential allergens affecting your health.

The Allergy-Banana f92 test measures various health markers related to banana allergies. This test is essential for individuals who suspect they have an allergy to bananas, helping to identify specific sensitivities and guide dietary choices.

The Allergy-Barley F6 test measures various health markers related to allergic reactions to barley. This test is essential for identifying sensitivities and managing allergic conditions effectively.

The Allergy-Beef f27 test measures various health markers related to beef allergies. This test helps identify specific immune responses to beef proteins, aiding in the diagnosis and management of allergic reactions.

The Allergy-Blomia tropicalis (d201) test measures various health markers related to allergic reactions. This test is essential for identifying sensitivities to the Blomia tropicalis allergen, which can contribute to respiratory and skin conditions.

The Allergy-Brazil Nut (f18) test measures various health markers related to allergic reactions to Brazil nuts. This test is essential for individuals who suspect they may have a nut allergy, providing crucial information for diagnosis and management.

The Allergy-Buckwheat f11 test measures various health markers related to allergic reactions to buckwheat. This test is essential for identifying sensitivities that may lead to allergic symptoms, helping to guide dietary choices and management.

The Allergy-Candida albicans m5 test measures various health markers related to allergic reactions to Candida albicans, a common yeast. This test helps in identifying sensitivities and potential allergic responses, providing valuable insights for effective management.

The Allergy-Carrot f31 test measures various health markers related to carrot allergies. This test helps identify allergic reactions and sensitivities to carrots, providing valuable information for managing dietary choices and health.

The Allergy-Casein f78 test measures various health markers related to sensitivity to casein, a protein found in milk. This test is essential for individuals who suspect a milk allergy or intolerance, providing valuable insights into their immune response.

The Allergy-Cashew Nut f202 test measures various health markers to assess allergic reactions to cashew nuts. This test is essential for individuals who suspect they have a nut allergy and need to understand their sensitivity levels.

The Allergy-Cauliflower f291 test measures various health markers related to allergic reactions. This test is essential for identifying sensitivities to cauliflower and can help guide dietary choices and management of allergy symptoms.

The Allergy-Celery f85 test measures various health markers related to celery allergies. This test is essential for individuals who suspect they have an allergy to celery, providing crucial information for diagnosis and management.

The Allergy-Chicken f83 test measures various health markers related to allergic reactions to chicken. This test is essential for individuals experiencing allergy symptoms and helps in diagnosing and managing food allergies effectively.

The Allergy-ChickPea test measures various health markers related to allergic reactions to chickpeas. This test is essential for individuals who suspect they have an allergy to chickpeas, providing valuable insights for diagnosis and management.

The Allergy-Clove f268 test measures various health markers related to allergic reactions to clove. This test is essential for identifying sensitivities and managing allergic conditions effectively.

The Allergy-Cockroach i6 test measures various health markers related to cockroach allergens. This test is essential for individuals experiencing allergic reactions or asthma symptoms triggered by cockroach exposure.

The Allergy-Coconut f36 test measures various health markers related to coconut allergies. It is essential for identifying allergic reactions and monitoring sensitivity to coconut products.

The Allergy-Codfish f3 test measures various health markers related to allergic reactions to codfish. This test is essential for individuals who suspect they have a fish allergy, providing critical information for diagnosis and management.

The Allergy-Corn f8 test is designed to measure various health markers related to corn allergies. This test helps in identifying specific allergic reactions and can guide treatment options for affected individuals.

The Allergy-Dermatophagoides farinae (d2) test measures various health markers related to allergic reactions to dust mites. This test is essential for diagnosing and managing allergies, helping healthcare providers tailor treatment plans effectively.

The Allergy-Dermatophagoides microceras test measures various health markers related to allergic reactions to dust mites. This test is essential for individuals experiencing allergy symptoms, helping to identify specific allergens and guide treatment options.

The Allergy-Dermatophagoides pteronyssinus test measures various health markers related to allergic reactions to dust mites. This test is essential for individuals experiencing allergy symptoms and helps in diagnosing and managing allergic conditions effectively.

The Allergy-Dog e5 test measures various health markers related to dog allergies. This test helps identify specific allergens that may be affecting your health, providing valuable information for diagnosis and management.

The Allergy-Egg White f1 test measures various health markers related to egg white allergies. This test is essential for identifying allergic reactions and guiding dietary choices for those affected by egg allergies.

The Allergy-Egg Yolk f75 test measures various health markers related to egg yolk allergies. It helps identify allergic reactions and sensitivities, providing crucial information for dietary management and treatment options.

The Allergy-Eucalyptus t18 test measures various health markers related to allergic reactions to eucalyptus. This test is essential for identifying sensitivities that may lead to allergic symptoms, helping in the management and treatment of allergies.

The Allergy-Euroglyphus maynei (d74) test measures various health markers related to allergic reactions. This test is essential for identifying sensitivities to specific allergens, helping in the management of allergic conditions.

The Allergy-Garlic f47 test measures various health markers related to garlic sensitivity. This test is essential for individuals experiencing allergic reactions or intolerances to garlic, providing valuable insights into their health.

The Allergy-Gluten f79 test measures various health markers related to gluten sensitivity and allergies. This test is essential for individuals experiencing symptoms associated with gluten intolerance, providing valuable insights into their health status.

The Allergy-Glycyphagus domesticus d73 test measures various health markers related to allergies. This test is essential for identifying sensitivities to the Glycyphagus domesticus allergen, which can help in managing allergic reactions effectively.

The Allergy-Hazel Nut f17 test measures various health markers related to allergic reactions to hazelnuts. This test is essential for individuals who suspect they may have an allergy to this nut, providing critical information for diagnosis and management.

The Allergy-Honey Bee Venom i1 test measures various health markers related to allergic reactions to honey bee venom. This test is crucial for individuals who suspect they may have an allergy to bee stings, helping to identify specific sensitivities and guide management strategies.

The Allergy-House Dust Mite test measures various health markers related to allergic reactions to house dust mites. This test is essential for individuals experiencing allergy symptoms, helping to identify specific sensitivities and guide treatment options.

The Allergy-Kiwi f84 test measures various health markers related to kiwi allergies. This test helps identify potential allergic reactions and sensitivities, providing valuable information for managing dietary choices.

The Allergy-Lamb f88 test measures various health markers related to allergic reactions to lamb. This test is essential for individuals who suspect they have a sensitivity or allergy to lamb meat, helping to identify potential allergens in their diet.

The Allergy-Latex k82 test measures various health markers related to latex allergies. This test is essential for diagnosing and managing allergic reactions to latex, which can be severe in some individuals.

The Allergy-Lentil test measures various health markers related to allergic reactions to lentils. This test is essential for individuals who suspect they have a lentil allergy and helps in diagnosing and managing allergic conditions effectively.

The Allergy-Lobster f80 test measures various health markers related to allergic reactions to lobster. This test is essential for individuals who suspect they may have a seafood allergy, particularly to lobster, and helps in the diagnosis and management of allergic conditions.

The Allergy-Mango f91 test measures various health markers related to mango allergies. This test is essential for individuals who suspect they have an allergy to mangoes, helping to identify specific sensitivities.

The Allergy-Meadow g8 test measures various health markers related to allergic reactions. This comprehensive test helps identify specific allergens that may be affecting your health, providing valuable insights for effective management.

The Allergy-Mesquite t20 test measures various health markers related to allergic reactions to mesquite. This test helps identify sensitivities and can guide treatment options for individuals experiencing allergy symptoms.

The Allergy-Milk f2 test evaluates various health markers related to milk allergies. This test is essential for identifying allergic reactions and managing dietary restrictions effectively.

The Allergy-Mucor racemosus m4 test measures various health markers related to allergic reactions to the Mucor racemosus fungus. This test is essential for identifying sensitivities and guiding appropriate treatment options for affected individuals.

The Allergy-Mugwart w6 test measures various health markers related to allergic reactions. This test is essential for identifying sensitivities to mugwort pollen and can help guide treatment options for allergy sufferers.

The Allergy-Mustard test is designed to measure various health markers related to mustard allergies. This test helps identify specific allergic reactions and sensitivities, providing crucial information for effective management and treatment.

The Allergy-Oak t7 test measures various health markers related to allergic reactions to oak pollen. This test is essential for individuals experiencing allergy symptoms during oak pollen season, providing valuable insights into their immune response.

The Allergy-Olive test measures various health markers related to allergic reactions to olive pollen. This test is essential for individuals experiencing allergy symptoms, helping to identify specific allergens and guide treatment options.

The Allergy-Onion f48 test measures various health markers related to onion allergies. This test helps identify allergic reactions and sensitivities to onions, providing valuable information for managing dietary choices.

The Allergy-Orange f33 test measures various health markers related to allergic reactions to oranges. This test is essential for identifying sensitivities and guiding dietary choices for individuals with suspected allergies.

The Allergy-Pork f26 test measures various health markers related to allergic reactions to pork. This test is essential for individuals who suspect they have a pork allergy, providing critical information for diagnosis and management.

The Allergy-Timothy g6 test evaluates various health markers related to allergic reactions, specifically to Timothy grass pollen. This test is essential for individuals experiencing allergy symptoms to determine sensitivity and guide management strategies.

The Allergy-Tomato f25 test measures various health markers related to tomato allergies. This test helps identify specific allergic responses to tomatoes, providing valuable information for managing dietary choices and allergy-related symptoms.

The Allergy-Tyrophagus putrescentiae test measures various health markers related to allergic reactions to the Tyrophagus putrescentiae mite. This test is essential for individuals experiencing allergy symptoms to determine specific sensitivities and guide treatment options.

The Allergy-Walnut f256 test measures various health markers related to walnut allergies. This test helps in identifying allergic reactions and monitoring sensitivity to walnuts, providing crucial information for effective management.

The Allergy-Wheat f4 test measures various health markers related to wheat sensitivity and allergy. This test is essential for identifying potential allergic reactions to wheat, helping to guide dietary choices and management strategies.

The Allergy-Willow Tree T12 test measures various health markers related to allergic reactions to willow trees. This test is essential for identifying sensitivities and managing allergy symptoms effectively.

The Allergy-Yeast f45 test measures various health markers related to yeast allergies. This test is essential for identifying sensitivities that may contribute to allergic reactions and other health issues.

The ANCA-C test measures various health markers related to autoimmune conditions. It is essential for diagnosing and monitoring diseases such as vasculitis and other inflammatory disorders.

The ANCA-P test measures the presence of anti-neutrophil cytoplasmic antibodies, which are important markers in diagnosing and monitoring autoimmune diseases. This test helps evaluate various health markers associated with conditions such as vasculitis and other inflammatory disorders.

The Anti Endomysium IgA Antibodies test measures specific antibodies that may indicate the presence of celiac disease or gluten sensitivity. This test is essential for diagnosing and monitoring conditions related to gluten intolerance.

The Anti Neutrophilic Cytoplasmic Antibody (ANCA) test measures various health markers associated with autoimmune diseases. It helps in the diagnosis and monitoring of conditions such as vasculitis and other inflammatory disorders.

The Anti-Endomysium Antibody, IgA test measures various health markers related to autoimmune disorders, particularly celiac disease. This test is crucial for diagnosing conditions that affect the intestines and can help monitor disease progression.

The Anti-Endomysium Antibody, IgG test is used to detect specific antibodies that may indicate autoimmune disorders, particularly celiac disease. This test measures various health markers related to gluten sensitivity and intestinal health.

The Anti-Toxoplasma Antibodies, IgG test measures the presence of immunoglobulin G (IgG) antibodies against Toxoplasma gondii, a parasite that can cause serious infections, particularly in immunocompromised individuals and pregnant women. This test helps determine past exposure to the parasite and assess the risk of congenital transmission during pregnancy.

The Anti-Toxoplasma Antibodies, IgM test measures the presence of IgM antibodies in the blood, which indicates a recent infection with Toxoplasma gondii, a parasite that can cause serious health issues, particularly in pregnant women and immunocompromised individuals. This test is crucial for diagnosing acute toxoplasmosis and guiding appropriate treatment.

The Antistreptolysin 'O' (ASO) quantitative test measures the level of antibodies produced by the body in response to a Streptococcus infection. This test is essential for diagnosing conditions such as rheumatic fever and post-streptococcal glomerulonephritis, helping healthcare providers assess the severity and duration of an infection.

The Antistreptolysin 'O' (ASO) Titre test measures the level of antibodies produced by the body in response to streptococcal infection. This test is essential for diagnosing conditions such as rheumatic fever and post-streptococcal glomerulonephritis, helping healthcare providers assess the presence of a recent streptococcal infection.

The CH 50 Complement Total Serum test measures various health markers related to the complement system, which plays a crucial role in immune response. This test can help assess the functionality of the complement pathway and detect potential immune deficiencies or inflammatory conditions.

The Cholinesterase test measures the levels of cholinesterase enzymes in the blood, which play a crucial role in the breakdown of neurotransmitters. This test is essential for diagnosing conditions related to nerve function and assessing exposure to certain toxins or medications.

The Complement 3 Level test measures the concentration of complement component 3 in the blood, which plays a crucial role in the immune system. This test helps assess various health markers related to immune function and inflammation.

The Complement 4 Level test measures various health markers related to the immune system. This test helps in assessing the complement system's function, which plays a crucial role in immune responses and inflammation.

The Coomb's Test - Direct, also known as the Direct Antiglobulin Test (DAT), is a crucial diagnostic tool used to detect the presence of antibodies that may be bound to red blood cells. This test is essential for diagnosing conditions such as hemolytic anemia and assessing compatibility in blood transfusions.

The Indirect Coomb's Test (Titer) is a blood test that measures the presence of antibodies against red blood cells. This test is crucial for diagnosing conditions such as hemolytic anemia and for ensuring safe blood transfusions by identifying potential incompatibilities.

The Cryoglobulin (Qualitative) test measures the presence of cryoglobulins in urine, which are abnormal proteins that can precipitate in cooler temperatures. This test is essential for diagnosing conditions associated with cryoglobulinemia, such as autoimmune disorders and certain infections.

The IgA level test measures the concentration of Immunoglobulin A (IgA) in the blood, an essential antibody that plays a crucial role in the immune system. This test is often used to evaluate immune function and diagnose conditions related to immune deficiencies or autoimmune disorders.

The IgG level test measures the concentration of Immunoglobulin G (IgG) antibodies in the blood, which play a crucial role in the immune system by fighting off infections. This test is essential for diagnosing various immune disorders, assessing immune function, and monitoring certain diseases.

The IgM level test measures the concentration of Immunoglobulin M (IgM) antibodies in the blood. This test is crucial for diagnosing recent infections and assessing the immune response, as IgM antibodies are typically the first antibodies produced by the body in response to an infection.

The Immunoglobulin D (IgD) Level test measures the concentration of IgD antibodies in the serum, providing insights into various health markers. This test is essential for understanding immune function and can help in diagnosing certain conditions related to immune response.

The Immunoglobulin E (IgE) test measures the level of IgE antibodies in the blood, which are involved in allergic reactions and responses to parasitic infections. Elevated IgE levels may indicate allergies, asthma, or other immune system disorders. This test is essential for diagnosing and monitoring various health conditions.

The Immunoglobulin IgD Heavy Chain test measures various health markers related to immune function. This test is essential for assessing specific immunoglobulin levels that may indicate underlying health conditions.

The Immunoglobulin Panel measures various health markers related to immune function, including IgG, IgM, and IgA levels. This test helps assess the body's immune response and can be crucial in diagnosing immunodeficiencies and infections.

The MPO antibody (P-ANCA) test measures various health markers related to autoimmune diseases. This test is essential for diagnosing conditions such as vasculitis and other inflammatory disorders, helping healthcare providers assess a patient's immune response.

The Neutrophil Cytoplasmic Antibodies (ANCA) test measures various health markers related to autoimmune disorders. This test is essential for diagnosing conditions such as vasculitis and other inflammatory diseases. It helps in monitoring disease activity and treatment response.

The PR3 antibody (C-ANCA) test is a crucial diagnostic tool used to measure various health markers associated with autoimmune conditions. It helps in the detection and monitoring of diseases such as granulomatosis with polyangiitis. Accurate results can guide effective treatment plans.

Autoantibody associated with rheumatoid arthritis.

The Toxoplasma Antibodies, IgM test measures the presence of IgM antibodies in the blood, which indicates a recent infection with the Toxoplasma gondii parasite. This test is crucial for diagnosing acute toxoplasmosis, particularly in pregnant women and immunocompromised individuals.

The Varicella Zoster antibody IgG test measures the presence of IgG antibodies against the Varicella Zoster virus, which causes chickenpox and shingles. This test is essential for determining immunity to the virus, especially in individuals who may be at risk of infection or complications from the disease.

The Varicella Zoster antibody IgM test measures the presence of IgM antibodies against the Varicella Zoster virus, which causes chickenpox and shingles. This test is crucial for diagnosing recent infections and assessing immunity status, particularly in patients with symptoms suggestive of varicella infection.